RHY 8.57% 7.6¢ rhythm biosciences limited

Ann: ColoSTAT abstracts accepted at 2023 ASCO Annual Meeting, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 556 Posts.
    lightbulb Created with Sketch. 80
    Yeah. I know what ASCO is lmao. I also know there’s many other companies presenting CRC indications and have presented very recently.



    https://hotcopper.com.au/data/attachments/5191/5191147-a84eda2c7f93bde98ec0e79cfca2941d.jpg

    please tell me more about how pivotal this announcement really is!

    That table was from ASCO- GI January 19th 2023. The more important one focussing on gastrointestinal cancers. RHY must’ve missed that one. Don’t worry they have many more they can go to. I’d be wary of venture capital wanting to back anything though. SVB funded a lot of healthcare (4/5 IPOs actually) and well that bank doesn’t exist anymore.

    But who knows RHY will present out of about 2000+ abstracts. There were over 2000 in 2022. Hrmm wonder why they didn’t go to that one? Or the one aforementioned?

    Otto an da boys going for a holiday!
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.